BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 33275044)

  • 1. In-vitro red blood cell partitioning of doxycycline.
    Deshmukh PV; Badgujar PC; Gatne MM
    Indian J Pharmacol; 2009 Aug; 41(4):173-5. PubMed ID: 20523868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics.
    Hinderling PH
    Pharmacol Rev; 1997 Sep; 49(3):279-95. PubMed ID: 9311024
    [No Abstract]   [Full Text] [Related]  

  • 3. A Phase I, Open-Label, Mass Balance Study of [
    Cheng Y; Wang X; Liu L; Silva J; Thomas M; Li Y
    Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):355-365. PubMed ID: 38521893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept.
    Jacobs CM; Radosa JC; Wagmann L; Zimmermann JSM; Kaya AC; Aygün A; Edel T; Stotz L; Ismaeil M; Solomayer EF; Meyer MR
    Anal Bioanal Chem; 2024 May; 416(12):2969-2981. PubMed ID: 38488952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel.
    Alsmadi MM; Jaradat MM; Obaidat RM; Alnaief M; Tayyem R; Idkaidek N
    AAPS PharmSciTech; 2023 Aug; 24(6):172. PubMed ID: 37566183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor.
    Yang X; Liu A; Yang L; Wen T; Wang J; Shi J; Zhou H; Chen Z; Lei M; Zhu Y
    Drug Des Devel Ther; 2022; 16():3087-3107. PubMed ID: 36124108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results using a kit to measure tamoxifen and metabolites concentrations in capillary blood samples from women with breast cancer.
    Rehnmark S; Shabo I; Randahl H; Wengström Y; Rydberg P; Hedayati E
    Sci Rep; 2022 Jan; 12(1):1643. PubMed ID: 35102224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics of U-47700, tramadol, and their main metabolites in pigs following intravenous administration: is a multiple species allometric scaling approach useful for the extrapolation of toxicokinetic parameters to humans?
    Nordmeier F; Sihinevich I; Doerr AA; Walle N; Laschke MW; Lehr T; Menger MD; Schmidt PH; Meyer MR; Schaefer N
    Arch Toxicol; 2021 Dec; 95(12):3681-3693. PubMed ID: 34604914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug transport by red blood cells.
    Biagiotti S; Pirla E; Magnani M
    Front Physiol; 2023; 14():1308632. PubMed ID: 38148901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS; Foster RT
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood or plasma: what is the ideal matrix for pharmacokinetic-driven drug candidate selection?
    Dash RP; Veeravalli V; Thomas JA; Rosenfeld C; Mehta N; Srinivas NR
    Future Med Chem; 2021 Jan; 13(2):157-171. PubMed ID: 33275044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.
    AbuTarif MA; Taft DR
    Pharm Res; 2002 Apr; 19(4):551-5. PubMed ID: 12033394
    [No Abstract]   [Full Text] [Related]  

  • 13. Time course and disposition of methazolamide in human plasma and red blood cells.
    Bayne WF; Tao FT; Rogers G; Chu LC; Theeuwes F
    J Pharm Sci; 1981 Jan; 70(1):75-81. PubMed ID: 6785411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.
    Iyer GR; Bellantone RA; Taft DR
    J Pharmacokinet Biopharm; 1999 Feb; 27(1):45-66. PubMed ID: 10533697
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.